The data showed that the expression of miR-223 was increased in biopsies from active IBD patients and that miR-223-deficient mice exhibit exacerbated experimental DSS-colitis characterized by increased NLRP3 inflammasome activation, and elevated IL1β production in the colon. This evidence concerns the gene NLRP3 and colitis.